<DOC>
	<DOC>NCT00605410</DOC>
	<brief_summary>Certain lung disease medications can influence diagnostic tests and research investigations. This study will investigate how long ipratropium bromide must be withheld before a methacholine challenge test can be conducted. This information will be useful for validating current guidelines.</brief_summary>
	<brief_title>Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Hypersensitivity</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Methacholine Chloride</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Diagnosis of asthma; stable and controlled FEV1 greater than or equal to 65% predicted Concomitant lung disease other than asthma</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Methacholine bronchoprovocation</keyword>
	<keyword>Antimuscarinic</keyword>
</DOC>